Shinjo K - Search Results

1

The Brain Microenvironment Induces DNMT1 Suppression and Indolence of Metastatic Cancer Cells.

Hirata E, Ishibashi K, Kohsaka S, Shinjo K, Kojima S, Kondo Y, Mano H, Yano S, Kiyokawa E, Sahai E. Hirata E, et al. Among authors: shinjo k. iScience. 2020 Aug 20;23(9):101480. doi: 10.1016/j.isci.2020.101480. eCollection 2020 Sep 25. iScience. 2020. PMID: 32891059 Free PMC article.

2

[Targeting epigenetics plasticity as a novel target for human neoplasia].

Shinjo K, Kondo Y. Shinjo K, et al. Gan To Kagaku Ryoho. 2010 Sep;37(9):1654-8. Gan To Kagaku Ryoho. 2010. PMID: 20841927 Japanese.

3

Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis.

Ju HX, An B, Okamoto Y, Shinjo K, Kanemitsu Y, Komori K, Hirai T, Shimizu Y, Sano T, Sawaki A, Tajika M, Yamao K, Fujii M, Murakami H, Osada H, Ito H, Takeuchi I, Sekido Y, Kondo Y. Ju HX, et al. Among authors: shinjo k. Am J Pathol. 2011 Apr;178(4):1835-46. doi: 10.1016/j.ajpath.2010.12.045. Epub 2011 Mar 4. Am J Pathol. 2011. PMID: 21406167 Free PMC article.

4

Activation of the PI3K-AKT pathway in human malignant mesothelioma cells.

Suzuki Y, Murakami H, Kawaguchi K, Tanigushi T, Fujii M, Shinjo K, Kondo Y, Osada H, Shimokata K, Horio Y, Hasegawa Y, Hida T, Sekido Y. Suzuki Y, et al. Among authors: shinjo k. Mol Med Rep. 2009 Mar-Apr;2(2):181-8. doi: 10.3892/mmr_00000081. Mol Med Rep. 2009. PMID: 21475810

5

Clinical implications of epigenetic alterations in human thoracic malignancies: epigenetic alterations in lung cancer.

Shinjo K, Kondo Y. Shinjo K, et al. Methods Mol Biol. 2012;863:221-39. doi: 10.1007/978-1-61779-612-8_13. Methods Mol Biol. 2012. PMID: 22359296 Review.

6

Contribution of microRNA-1275 to Claudin11 protein suppression via a polycomb-mediated silencing mechanism in human glioma stem-like cells.

Katsushima K, Shinjo K, Natsume A, Ohka F, Fujii M, Osada H, Sekido Y, Kondo Y. Katsushima K, et al. Among authors: shinjo k. J Biol Chem. 2012 Aug 10;287(33):27396-406. doi: 10.1074/jbc.M112.359109. Epub 2012 Jun 26. J Biol Chem. 2012. PMID: 22736761 Free PMC article.

7

Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.

Natsume A, Ito M, Katsushima K, Ohka F, Hatanaka A, Shinjo K, Sato S, Takahashi S, Ishikawa Y, Takeuchi I, Shimogawa H, Uesugi M, Okano H, Kim SU, Wakabayashi T, Issa JP, Sekido Y, Kondo Y. Natsume A, et al. Among authors: shinjo k. Cancer Res. 2013 Jul 15;73(14):4559-70. doi: 10.1158/0008-5472.CAN-13-0109. Epub 2013 May 29. Cancer Res. 2013. PMID: 23720055

8

RASSF3 downregulation increases malignant phenotypes of non-small cell lung cancer.

Fukatsu A, Ishiguro F, Tanaka I, Kudo T, Nakagawa K, Shinjo K, Kondo Y, Fujii M, Hasegawa Y, Tomizawa K, Mitsudomi T, Osada H, Hata Y, Sekido Y. Fukatsu A, et al. Among authors: shinjo k. Lung Cancer. 2014 Jan;83(1):23-9. doi: 10.1016/j.lungcan.2013.10.014. Epub 2013 Oct 31. Lung Cancer. 2014. PMID: 24246507

9

Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer.

Ichimura N, Shinjo K, An B, Shimizu Y, Yamao K, Ohka F, Katsushima K, Hatanaka A, Tojo M, Yamamoto E, Suzuki H, Ueda M, Kondo Y. Ichimura N, et al. Among authors: shinjo k. Cancer Prev Res (Phila). 2015 Aug;8(8):702-11. doi: 10.1158/1940-6207.CAPR-14-0306. Epub 2015 Jun 10. Cancer Prev Res (Phila). 2015. PMID: 26063725

10

Targeting cancer epigenetics: Linking basic biology to clinical medicine.

Shinjo K, Kondo Y. Shinjo K, et al. Adv Drug Deliv Rev. 2015 Dec 1;95:56-64. doi: 10.1016/j.addr.2015.10.006. Epub 2015 Oct 19. Adv Drug Deliv Rev. 2015. PMID: 26494398 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page